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Abstract
Within adipose tissue, multiple leukocyte interactions contribute to metabolic homeostasis in 
health as well as to the pathogenesis of insulin resistance with obesity. Adipose tissue 
macrophages (ATMs) are the predominant leukocyte population in fat and contribute to obesity-
induced inflammation. Characterization of ATMs and other leukocytes in the stromal vascular 
fraction from fat has benefited from the use of flow cytometry and flow-assisted cell sorting 
techniques. These methods permit the immunophenotyping, quantification, and purification of 
these unique cell populations from multiple adipose tissue depots in rodents and humans. Proper 
isolation, quantification, and characterization of ATM phenotypes are critical for understanding 
their role in adipose tissue function and obesity-induced metabolic diseases. Here, we present the 
flow cytometry protocols for phenotyping ATMs in lean and obese mice employed by our 
laboratory.
1. INTRODUCTION
Obesity induces a low-grade inflammatory state that contributes to insulin resistance, 
diabetes, and metabolic syndrome (Glass & Olefsky, 2012; Gregor & Hotamisligil, 2011; 
Lumeng & Saltiel, 2011; Xu et al., 2003). Obesity-induced inflammation is characterized by 
chronic elevations in circulating inflammatory cytokines, adipokines, and monocytes 
(Gregor & Hotamisligil, 2011). At the tissue level, inflammatory pathways are induced in 
visceral adipose tissue due in part to dynamic quantitative and phenotypic changes in 
adipose tissue leukocytes, which include macrophages, neutrophils, mast cells, T cells, and 
eosinophils (Liu et al., 2009; Nishimura et al., 2009; Strissel et al., 2010; Talukdar et al., 
2012; Wu et al., 2011). Among these, adipose tissue macrophages (ATMs) are the 
predominant leukocyte population in fat (Nishimura et al., 2009; Wentworth et al., 2010). In 
both mouse models and human subjects, obesity leads to increased ATM accumulation in 
visceral adipose depots (Harman-Boehm et al., 2007; Weisberg et al., 2003; Xu et al., 2003). 
In mouse models, ATM content can increase from ~10% to 15% of nonadipocyte cells in fat 
in lean mice to ~50% of cells in obese mice (Weisberg et al., 2003; Xu et al., 2003). ATM 
content positively correlates with the metabolic derangements associated with obesity in 
rodent and humans (Kanda et al., 2006; Wentworth et al., 2010; Xu et al., 2003).
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Obesity is also associated with qualitative changes in the phenotype and function of ATMs. 
In lean mice, resident ATMs are distributed between adipocytes in healthy adipose tissue 
and express anti-inflammatory markers typical of “alternatively activated” or M2-polarized 
macrophages (e.g., arginase 1, CD301/Mgl1, and CD206) (Lumeng, Bodzin, & Saltiel, 
2007). Dietary obesity triggers the accumulation of ATMs into “crown-like structures” 
around dead adipocytes (Cinti et al., 2005; Strissel et al., 2007). These infiltrating ATMs 
express the dendritic cell marker CD11c and genes typical of “classically activated” or M1-
polarized macrophages (Lumeng, Bodzin, & Saltiel, 2007). Recruited CD11c+ ATMs 
secrete proinflammatory cytokines such as TNF-α and IL-6 and generate reactive oxygen 
species via inducible nitric oxide synthase (NOS2) (Lumeng, DelProposto, Westcott, & 
Saltiel, 2008; Lumeng, Deyoung, Bodzin, & Saltiel, 2007). Collectively, these and other 
observations have led to the paradigm that ATMs undergo a “phenotypic switch” from an 
anti-inflammatory M2 state to a proinflammatory M1 state (Lumeng, Bodzin, & Saltiel, 
2007). While this is an oversimplification of a complex regulatory system, evidence from 
knockout mice support the general model M1/M2 balance in macrophages can play a pivotal 
role in the development of adipose tissue inflammation in obesity (Chawla, Nguyen, & Goh, 
2011; Lumeng & Saltiel, 2011).
The limited number and complex heterogeneity of stromal vascular cells (SVCs) isolated 
from fat depots poses a challenge on the types of analyses that can be applied to directly 
study ATMs. In vitro assays using bone marrow-derived macrophages or macrophage cell 
lines are limited in that they may not recapitulate the ATM microenvironment. The use of 
flow cytometry has emerged as the preferred method to interrogate ATM content and 
heterogeneity in mouse models. When done properly flow cytometry allows investigators to 
simultaneously examine both general cell properties (e.g., relative size and granularity) and 
expression of extracellular and intracellular proteins on individual cells isolated from fat. In 
concert with purification schemes such as immunomagnetic cell enrichment and flow-
assisted cell sorting (FACS), flow cytometry becomes an invaluable tool for studying ATMs 
and other leukocytes in adipose tissue. Technical approaches vary from laboratory to 
laboratory making it somewhat of a challenge to interpret data across studies. Much of this 
may stem from the use of collagenase digestion protocols originally developed for adipocyte 
isolation that may not adequately capture all leukocytes for downstream analysis (Rodbell, 
1964). In this chapter, we provide the protocol used by our group optimized for detection 
and purification of ATM subsets by flow cytometry. We provide several practical 
considerations for optimizing cell yield, for selecting proper reagents and flow cytometry 
controls, and for gating SVCs to characterize distinct ATM subsets.
2. MATERIALS
2.1. Isolation and preparation of SVCs from mice
1. C57BL/6J mice (The Jackson Laboratory, Bar harbor, ME; stock #00064)
2. Sterile or ethanol-cleaned surgical instruments
3. 70% Ethanol
4. 10 cc Luer-Lok syringes with needles (25G×1″)
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5. 1× Phosphate-buffered saline (PBS)
6. Digestion buffer: Hanks’ balanced salt solution with Ca2+ and Mg2+ supplemented 
with 0.5% bovine serum albumin (BSA)
7. 10× Collagenase solution (10 mg/ml in digestion buffer). Type II collagenase 
(Sigma-Aldrich; Catalog #C6885). Solution should be prepared freshly for optimal 
results and can be filter-sterilized (0.22 µm)
8. 100 µm Nylon cell strainers (BD Falcon; Catalog #352360)
9. 1× RBC lysis buffer: 155 mM NH4Cl, 10 mM KHCO3, 0.1 M EDTA; sterile 
filtered through 0.22-µm filter and store in aliquots at 4 °C
10. 0.5 M EDTA
11. FACS buffer: PBS with 1 mM EDTA, 25 mM HEPES, and 1% heat-inactivated 
fetal bovine serum (FBS)
12. Trypan blue solution, 0.4% (Invitrogen; Catalog #15250)
13. Refrigerated clinical centrifuge with swing-bucket rotors and adapters for 15- and 
50-ml conical tubes
14. Incubator set to 37 °C
15. Test tube rocker/mixer
16. Hemocytometer for counting cells
2.2. Staining SVCs for cell surface markers to identify ATMs
1. 5-ml Polystyrene round-bottom test tubes for flow cytometry (12×75 mm)
2. Fluorochrome-labeled anti-mouse monoclonal antibodies against indicated cell 
surface molecules (Table 16.1)
3. Viability dye: DAPI or Live/Dead Fixable Dead Cell Kit (Life Technologies; 
Catalog #L34955)
4. 16% Paraformaldehyde (PFA) (EM grade)
2.3. Flow cytometry analysis
1. Flow cytometer (e.g., FACSCanto II; BD Biosciences) equipped with three lasers 
(405-nm violet laser, 488-nm blue laser, and 640-nm red laser) and detectors for the 
indicated fluorochromes
2. SVCs stained with each individual fluorochrome-labeled antibody (single stained 
(SS) controls) and fluorescence minus one (FMO) controls (Table 16.2)
2.4. FACS procedure to purify ATM populations
1. Cell sorter (e.g., FACSAria II; BD Biosciences) equipped with three lasers (405-
nm violet laser, 488-nm blue laser, and 640-nm red laser) and detectors for the 
indicated fluorochromes
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2. FACS buffer: PBS with 1 mM EDTA, 25 mM HEPES, and 1% heat-inactivated 
FBS
2.5. Using magnetic beads and positive selection to enrich for CD11b+ SVCs
1. 5-ml Polystyrene round-bottom test tubes for flow cytometry (12×75 mm)
2. MACS buffer: PBS (without Ca2+ and Mg2+) supplemented with 0.5% BSA
3. CD11b microbeads (Miltenyi Biotec; Catalog #130-049-601)
4. MACS MS cell separation columns with corresponding MACS separator magnet 
(Miltenyi Biotec, Bergisch Gladbach, Germany)
2.6. Data analysis
1. Flow cytometry analysis software (e.g., FlowJo, TreeStar Inc., Ashland, OR)
3. METHODS
3.1. Isolation and preparation of SVCs from mice
In this section, we describe the dissection of mouse adipose tissue and subsequent recovery 
of SVCs by collagenase digestion. We recommend using at least one entire perigonadal fat 
pad for flow cytometry analysis and FACS because regional differences in the distribution 
of leukocytes in visceral fat from mouse models have been noted (Cho et al., 2007). 
Experimental design should also account for the need for additional SVCs for compensation 
controls, which will be explained in detail in Section 3.3. We have found that minced tissue 
size, shaking intensity, and incubation time in collagenase buffer are critical parameters that 
should be optimized to maximize the yield of viable SVCs from visceral fat. Increasing 
surface area by finely mincing the tissue and frequent manual shaking during the digestion 
tends to increase SVC yield. Importantly, the duration of collagenase exposure should be 
empirically determined for each lot of collagenase. Increasing incubation times in 
collagenase buffer, especially longer than 1 h, significantly decrease SVC yield and increase 
cell death and should be avoided.
3.1.1 Isolation of adipose tissue
1. Euthanize mouse according to approved procedures and disinfect the skin with 70% 
ethanol.
2. Open the thoracic cavity to expose the heart. Perform a cardiac perfusion to remove 
blood from tissues. Using a 10 cc syringe and 25G needle, slowly perfuse the left 
ventricle with 10 ml of PBS. At the same time, puncture the right atria to allow 
blood and perfusate to escape the circulation.
3. Isolate the perigonadal adipose depot using sterile technique. Remove any visible 
gonadal tissue. When isolating mesenteric or inguinal adipose depots, care should 
be taken to remove lymph nodes.
4. Weigh the isolated fat pads and note the value. This weight will be used to 
normalize flow cytometry data.
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5. Wash the adipose tissue with PBS to remove any contaminants, such as fur, and 
place tissue in a plastic weigh boat on ice.
3.1.2 Isolation of SVCs by collagenase digestion
1. Mince adipose tissue into small pieces with scissors (approx. 3–5 mm in size) in a 
weigh boat on ice.
2. Transfer minced tissues (≤~1 g) into 10-ml round-bottom tube containing 7 ml of 
ice-cold digestion buffer and keep on ice. For fat pads >1 g, mince the tissue and 
transfer into a 50-ml conical tube containing 10 ml of ice-cold digestion buffer. 
When tissue is added to buffer, mince further, and return the tube to ice until all 
samples have been harvested.
3. Add 1 ml (or 1.5 ml for >1 g) of 10× collagenase buffer. Adjust the final 
concentration of collagenase to 1 mg/ml by adding additional digestion buffer.
4. Incubate at 37 °C for 20–45 min with vigorous shaking using a test tube rocker. 
Higher cell yields can be achieved when the tubes are vigorously shaken by hand 
every 10 min. After 30 min, 10 µl of the digestion mixture should be examined 
microscopically. At this point, adipocytes should appear as large single cells; 
leukocytes and other stromal cells will be much smaller. If leukocytes are still 
attached to adipocytes, the digestion should continue; if not, proceed to the next 
step.
5. After digestion, add EDTA to a final concentration of 10 mM and incubate at 37 °C 
for an additional 5–10 min. This step is necessary to facilitate full dissociation of 
SVCs; EDTA exposure should be limited to avoid adversely effecting cell viability.
6. Prewet a 100-µm nylon filter with PBS and place onto a 50-ml conical tube. Using 
a transfer pipette, transfer the bottom layer of cell slurry onto the filter, followed by 
the adipocyte containing upper layer. This prevents larger adipocytes from clogging 
the filter before SVCs can pass freely through. Wash the filter twice gently by 
adding 10 ml of FACS buffer.
7. Centrifuge cell slurry at 500×g for 10 min at 4 °C to separate adipocytes and SVCs. 
After centrifugation, adipocytes form a white layer on top while SVCs form a red/
white pellet on bottom of the tube.
8. Gently aspirate and discard adipocytes and supernatant. At this point, the SVC-
containing pellet will be easy to disturb, so great care should be taken. If necessary, 
adipocytes (floating layer) can be collected using a transfer pipette prior to 
aspiration.
9. Manually disrupt pellet by flicking the tube and resuspend in 0.5 ml RBC lysis 
buffer. Incubate 5 min at room temperature with occasional gently shaking.
10. Neutralize RBC lysis by adding 5 ml of FACS buffer.
11. Centrifuge at 500×g for 10 min at 4 °C. Resuspend cell pellets in 3–5 ml FACS 
buffer and incubate on ice.
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12. Mix 10 µl of each sample 1:1 with trypan blue solution. Count viable cells carefully 
using hemocytometer. The resulting cell number and total volume give an estimate 
of the number of SVCs per fat pad. Typical yields are 1–3×106 cells/g fat from lean 
mice, 2–5×106 cells/g fat from obese mice.
3.2. Staining SVCs for cell surface markers to identify ATMs
For multiparameter flow cytometry, the selection of antibodies and fluorochrome conjugates 
is a critical step (Baumgarth & Roederer, 2000; Maecker, Frey, Nomura, & Trotter, 2004). It 
has been our experience that ATMs from obese mouse fat have a significant amount of 
autofluorescence when excited by the blue laser (488 nm); thus, we try to avoid using FITC- 
or Alexa488-conjugated antibodies in our staining protocols for ATMs. The first step in 
selecting fluorochromes is to consider the flow cytometry or FACS instrument on which the 
samples will be analyzed. We recommend using instruments with at least a three-laser 
configuration (e.g., FACSCanto II equipped with 405 nm violet laser, 488 nm blue laser, and 
640 nm red laser) as this will provide the greatest flexibility and allow for five to seven 
colors to be detected; however, if such an instrument is not available, two-laser 
configurations (e.g., 488/640 nm or 561/640 nm) are the next best option. When selecting 
fluorochrome conjugates, it is generally recommended to use those with the highest staining 
index (e.g., PE, PE-Cy5, APC) for rare cellular events, but care must be taken to minimize 
spectral overlap. Detailed discussions of these issues are presented elsewhere (Baumgarth & 
Roederer, 2000; Maecker et al., 2004). Once the antibodies and fluorochrome conjugates 
have been chosen, preliminary experiments should be performed to titer the antibody 
concentrations to maximize separation of positive and negative cell populations. Based on 
the antibody selection and titration data, SVCs can be stained with antibody cocktails 
(containing antibodies at predetermined concentrations in staining buffer) as described in the 
basic protocol below. For controls, additional SVCs are stained with each antibody 
individually (SS controls) and the antibody cocktail minus one antibody (FMO controls). 
Table 16.2 shows a summary of the control tubes needed in this antibody panel.
1. Transfer 1×106 SVCs from Section 3.1 into a 5-ml polystyrene round-bottom tube 
and resuspend in 100 µl of FACS buffer to obtain a final concentration 1×107 
SVCs/ml. Note: When preparing cells for sorting, the total number of cells can be 
increased, but each reagent should be linearly increased as well.
2. Add 0.5–1 µg of Fc-block (anti-CD16/32) and incubate on ice for 10 min.
3. Repeat steps 1–2 for each control tube listed in Table 16.2. SVCs can be pooled 
from multiple mice for the SS and FMO controls. If cells are limiting, as few as 
1×105 SVCs can be used for control tubes.
4. For each sample, prepare an antibody staining cocktail for ATMs as indicated in 
Table 16.1. Bring the cocktail to 100 µl/sample by adding FACS buffer.
5. Add 100 µl of antibody cocktail to each sample tube.
6. Flick tube to mix.
7. For SS and FMO controls, add the antibody or antibodies as indicated in Table 
16.2.
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8. Incubate all tubes for 30 min at 4 °C protected from light.
9. Wash cells with 2 ml FACS buffer and centrifuge 10 min at 500×g at 4 °C.
10. Carefully, aspirate supernatants.
11. Wash cells again with 2 ml FACS buffer and centrifuge 10 min at 500×g at 4 °C.
12. Carefully, aspirate supernatants.
13. Optional (for flow cytometry analysis only): stain the samples and appropriate 
controls with viability dye (fixable live/dead stain). Dilute dye (1:500–1:1000) in 
200 µl PBS/sample. Incubate the cells in dye solution at room temperature for 30 
min. Repeat steps 9–12 to wash cells. Proceed to step 14.
14. For flow cytometry analysis, fix cells by adding 200 µl of 0.1% PFA. Cells can be 
stored in PFA at 4 °C in the dark until data acquisition. Prolonged exposure in PFA 
may increase autofluorescence; therefore, it is advisable to remove PFA after 1 h 
and replace with 200–300 µl of FACS buffer if cells will not be analyzed within 24 
h.
15. For sorting of viable cells by FACS, suspend cells in FACS buffer to obtain a final 
concentration suitable for sorting (generally 1–10×107/ml). Add DAPI (0.2 µg/ml) 
to each sample and appropriate controls to allow for live/dead cell discrimination. 
Protect tubes from light and place on ice for transport to the FACS instrument.
3.3. Flow cytometry analysis
3.3.1 Compensation procedures—As noted above, care should be taken to minimize 
emission spectra overlap when selecting fluorochrome-conjugated antibodies for ATMs. 
However, it is difficult to completely eliminate spectral overlap in multicolor staining. 
Therefore, it is necessary to perform a compensation procedure during each experiment 
before acquiring data from the samples of interest. Each instrument has a different 
compensation procedure, with some software packages generating a compensation matrix 
automatically from SS controls. Therefore, we recommend consulting the manual and 
following the manufacturer’s recommendations for your instrument. When compensation is 
correctly applied, the median fluorescence intensities (MFIs) of the positive and negate 
populations of the individual SS controls are aligned in all neighboring channels. It is 
important to use SS controls prepared from SVCs (Section 3.2, Step 3) because these cells 
will have the same properties as the samples of interest. Here, we provide a brief guide for 
getting started.
1. Using an unstained control sample, adjust side scatter and forward scatter so that 
the cell populations of interest are on scale.
2. Using the unstained control sample, adjust the photomultiplier tube (PMT) gain for 
each fluorochrome detector so that the peak MFI of the unstained cells on a 
histogram is within 101–102 on a log scale.
3. Acquire all SS compensation controls. If necessary, adjust the PMT gains for each 
detector so that the positive (stained) population can be discriminated from the 
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negative (unstained) cells. We acquire and save 10,000–30,000 events for each SS 
control.
4. Calculate compensation values across all included detector according to 
instructions for your instrument. Importantly, apply compensation values to all SS 
controls, FMO controls, and samples of interest.
3.3.2 Data acquisition
1. Using the same instrument settings, acquire all FMO controls individually. FMO 
controls contain all the antibodies in the staining cocktail, but one antibody is 
replaced with an isotype control. For example, FMO-APC contains the APC-
isotype antibody rather than APC-CD301 (Table 16.2). This is necessary for 
discriminating positive from negative populations during subsequent gating of the 
samples of interest. Acquire and save 10,000–30,000 events.
2. Acquire and save 10,000–50,000 events from the samples of interest. To generate 
statistically sound data for frequency determination, a sufficient number of events 
need to be obtained; this may require recording more than 50,000 events per 
sample.
3.3.3 Gating strategy to identify and characterize ATMs—Figure 16.1 depicts our 
general strategy for identifying M1 (CD11c+) and M2 (CD301+) ATMs for quantification 
and purification by FACS. Cell aggregates, dead cells (DAPI+), and cellular debris are first 
excluded (Fig. 16.1A). This step greatly reduces, but does not eliminate, autofluorescence in 
SVC preparations. Next, adipose tissue leukocytes (CD45+) are selected. ATMs from both 
lean and obese mice coexpress F4/80 and CD11b (Fig. 16.1A). However, F4/80mid cells 
(gate 2) contain eosinophils (Siglec-F+) and neutrophils (GR1+; Fig. 16.1B); therefore, care 
should be taken to gate ATMs as F4/80highCD11bhigh (gate 1) to minimize contamination 
with these cell types. Finally, viable CD45+F4/80highCD11bhigh ATMs are analyzed for 
surface expression of CD11c (M1 marker) and CD301 (M2 marker), which identify discrete 
M1 and M2 ATM subsets in both lean and obese mice (Figs. 16.1A and 16.3B).
3.4. FACS procedure to purify ATM populations
1. Prior to FACS, decide the number of desired target cells to be collected. Cells 
should be sorted directly into the appropriate media (e.g., cell culture media, lysis 
buffer) for the downstream application. Prepare enough collection tubes for the 
cells of interest.
2. Prepare SVCs from adipose tissue as described in Section 3.1.
3. Stain SVCs with antibody cocktail as described in Section 3.2. Cells should be 
transported to the FACS facility on ice and protected from light.
4. Set up the FACS instrument according to the manufacturer’s directions.
5. Run SS and FMO controls to setup compensation matrix and sorting gates.
6. Optimize the FACS instrument for sorting according to the manufacturer’s protocol 
and adjust speed of sample acquisition to optimize purity of the sample.
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7. Vortex the source cells and run a test sort.
8. Continue sorting cells until the desired cell number is achieved or the source cells 
are exhausted.
3.5. Using magnetic beads and positive selection to enrich for CD11b+ SVCs
In this section, we describe the enrichment of CD11b+ leukocytes from SVCs using 
magnetic beads and positive selection (Fig. 16.2). The majority of the cells in this pool will 
be ATMs but contamination with neutrophils and eosinophils will be likely. Downstream in 
vitro studies can further enrich for ATMs by adhesion to plastic.
1. In a 5-ml polystyrene round-bottom tube, suspend 107 SVCs in 90 µl of MACS 
buffer.
2. Add 10 µl of CD11b microbeads.
3. Mix well by flicking tube or very gently vortexing. Incubate for 15 min at 4 °C.
4. Wash cells by adding 1 ml of MACS buffer and centrifuge at 500×g for 10 min at 4 
°C. Discard supernatant.
5. Resuspend cell pellet in 500 µl of MACS buffer.
6. Place MS separation column in magnetic field of MACS separator. Equilibrate 
column by adding 500 µl of MACS buffer.
7. Apply cell suspension to center of column. Collect unlabeled (CD11b−) cells that 
pass through the column in a 5-ml tube.
8. Wash column three times with 500 µl of MACS buffer, allowing the column to 
empty with each wash. Do not allow the column to dry. Collected flow through 
(CD11b− fraction) can be assayed by flow cytometry if necessary.
9. Remove MS column from the magnetic field. Place in a 5-ml tube.
10. Add 1 ml of MACS buffer to the column. Using the provided plunger, expel the 
CD11b+ fraction into the tube.
11. Centrifuge cell fractions at 500×g for 5 min at 4 °C. Discard supernatant, and 
resuspend cell pellets in 300 µl of FACS buffer and stain for cell surface antigens 
or further analysis.
3.6. Data analysis
1. Analyze flow cytometry data with FlowJo software.
2. Determination the frequency of ATMs and ATM subsets as a percentage of total 
viable cells (Fig. 16.3C and D).
3. Based on the % of SVCs, ATM content can also be reported as absolute cell 
number (%ATMs×total SVC isolated), or normalized to adipose tissue mass 
(%ATMs×total SVCs/fat pad weight (g) (Fig. 16.3C and D).
4. Perform statistical analysis.
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4. DISCUSSION
The approach presented here has evolved over the years in our laboratory and has undergone 
a variety of refinements to best assess ATM in a variety of mouse models (Lumeng et al., 
2011; Morris et al., 2013; Morris, Oatmen, Wang, DelProposto, & Lumeng, 2012; Singer et 
al., 2013; Westcott et al., 2009). Such techniques provide the most reliable quantitation of 
ATM content and assess the balance between proinflammatory M1 (CD11c+) ATMs and 
anti-inflammatory M2 (CD301+) ATMs in lean and obese mice. This FACS strategy has 
also been successfully used to purify ATMs for gene expression analysis and functional 
assays (Morris et al., 2013; Singer et al., 2013). While similar principles may apply for 
analysis of human ATMs, Hagman et al. (2012) provide an excellent strategy specifically 
tailored to human samples.
In our experience, the most critical steps in the protocol are efficient digestion of adipose 
tissue by collagenase and proper staining and compensation of SVCs. We have found that 
gentle extraction techniques optimized for study of adipocyte function do not efficiently 
remove ATMs from the floating adipocytes during the differential centrifugation step. The 
upper layer can be contaminated with lipid-laden ATMs, which are buoyant, with ATMs 
that remain attached to adipocytes without vigorous digestion. Attempts to combine analysis 
of SVCs with adipocyte function have been challenging, as digestion strategies need to be 
optimized for each application.
Our strategy to identify ATMs is based on initial observations that macrophages in adipose 
tissues coexpress F4/80 and CD11b (Weisberg et al., 2003). Since then, it has been 
established that F4/80mid cells in fat from mice can also contain eosinophils (Siglec-F+) and 
neutrophils (GR-1+), although they are minor populations compared to ATMs (Fig. 16.1B) 
(Talukdar et al., 2012; Wu et al., 2011). In our staining protocols, ATMs are best identified 
as F4/80highCD11bhigh (Fig. 16.1A; gate 1).
How to appropriately normalize ATM data from flow cytometry continues to be a challenge 
in fat depots that massively expand in size due to adipocyte hypertrophy. In our example 
data (Fig. 16.3C), SVCs from lean mice contains 9% ATMs and high-fat diet (HFD) 
exposure for 12 weeks increased ATM content to 15% (1.6-fold increase). However, the 
absolute and relative (cells/g fat) number of ATMs increased approximately threefold (Fig. 
16.3C). In agreement with previous reports (Li et al., 2010; Lumeng et al., 2008), HFD-
induced obesity also altered the distribution of M1 and M2 ATM subtypes in visceral fat 
(Fig. 16.3B and D). ATM content and the frequencies of M1 versus M2 ATMs obtained 
here are comparable to other studies (Weisberg et al., 2003; Xu et al., 2003), indicating that 
our flow cytometry method provides a simple and reproducible method for assessing the 
content and heterogeneity of ATMs in mice models.
One obstacle that limits flow analysis is the significant cellular autofluorescence of adipose 
SVCs and ATMs. Especially in obese mice, ATMs are embedded in the autofluorescent 
SSChiFSChi populations of cells that are prominent in the SVC. Analyses should not exclude 
these cells as this will significantly underreport ATM content. Gating to exclude dead cells, 
debris, and cell aggregates can improve results, but a significant amount of autofluorescence 
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from ATMs remains likely due to high lipid content. In our experience, these limitations 
almost completely exclude the routine use of FITC- and Alexa488-conjugated monoclonal 
antibodies for macrophages in staining cocktails. This limitation can be partially overcome 
by using flow cytometers with yellow–green (561 nm) lasers versus the conventional blue 
(488 nm) laser configuration (Morris, D.L., unpublished observation).
For those starting such a procedure for the first time, consultation with flow cytometry 
experts is highly recommended prior to performing experiments. Over time this protocol has 
been shown to give highly reproducible results and we feel is a good starting point for those 
looking to examine ATMs in their mouse models. Additional refinements of the protocol 
should continue by all groups in this field as it continues in our laboratory.
Acknowledgments
K. W. C. and C. N. L. are supported by NIH grants DK090262 and DK092873 and a Career Development Award 
from the American Diabetes Association. D. L. M. was supported by NIH NRSA award DK091976.
REFERENCES
Baumgarth N, Roederer M. A practical approach to multicolor flow cytometry for 
immunophenotyping. Journal of Immunological Methods. 2000; 243(1–2):77–97. [PubMed: 
10986408] 
Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nature 
Reviews. Immunology. 2011; 11(11):738–749. http://dx.doi.org/10.1038/nri3071. 
Cho CH, Koh YJ, Han J, Sung HK, Jong Lee H, Morisada T, et al. Angiogenic role of LYVE-1-
positive macrophages in adipose tissue. Circulation Research. 2007; 100(4):e47–e57. [PubMed: 
17272806] 
Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines 
macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid 
Research. 2005; 46(11):2347–2355. [PubMed: 16150820] 
Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell 
Metabolism. 2012; 15(5):635–645. [PubMed: 22560216] 
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annual Review of Immunology. 
2011; 29:415–445.
Hagman DK, Kuzma JN, Larson I, Foster-Schubert KE, Kuan LY, Cignarella A, et al. Characterizing 
and quantifying leukocyte populations in human adipose tissue: Impact of enzymatic tissue 
processing. Journal of Immunological Methods. 2012; 386(1–2):50–59. [PubMed: 22974837] 
Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, et al. Macrophage 
infiltration into omental versus subcutaneous fat across different populations: Effect of regional 
adiposity and the comorbidities of obesity. The Journal of Clinical Endocrinology and Metabolism. 
2007; 92(6):2240–2247. [PubMed: 17374712] 
Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, et al. MCP-1 contributes to 
macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. The 
Journal of Clinical Investigation. 2006; 116(6):1494–1505. [PubMed: 16691291] 
Li P, Lu M, Nguyen MT, Bae EJ, Chapman J, Feng D, et al. Functional heterogeneity of CD11c-
positive adipose tissue macrophages in diet-induced obese mice. The Journal of Biological 
Chemistry. 2010; 285(20):15333–15345. [PubMed: 20308074] 
Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, et al. Genetic deficiency and 
pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. 
Nature Medicine. 2009; 15(8):940–945.
Cho et al. Page 11
Methods Enzymol. Author manuscript; available in PMC 2014 November 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue 
macrophage polarization. The Journal of Clinical Investigation. 2007; 117(1):175–184. [PubMed: 
17200717] 
Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue 
macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. 
Diabetes. 2008; 57(12):3239–3246. [PubMed: 18829989] 
Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose 
tissue macrophages recruited during diet-induced obesity. Diabetes. 2007; 56(1):16–23. [PubMed: 
17192460] 
Lumeng CN, Liu J, Geletka L, Delaney C, Delproposto J, Desai A, et al. Aging is associated with an 
increase in T cells and inflammatory macrophages in visceral adipose tissue. Journal of 
Immunology. 2011; 187(12):6208–6216.
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. The Journal of 
Clinical Investigation. 2011; 121(6):2111–2117. [PubMed: 21633179] 
Maecker HT, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum 
sensitivity. Cytometry. Part A: The Journal of the International Society for Analytical Cytology. 
2004; 62(2):169–173. [PubMed: 15536642] 
Morris DL, Cho KW, Delproposto JL, Oatmen KE, Geletka LM, Martinez-Santibanez G, et al. 
Adipose tissue macrophages function as antigen presenting cells and regulate adipose tissue CD4+ 
T cells in mice. Diabetes. 2013; 62(8):2762–2772. [PubMed: 23493569] 
Morris DL, Oatmen KE, Wang T, DelProposto JL, Lumeng CN. CX3CR1 deficiency does not 
influence trafficking of adipose tissue macrophages in mice with diet-induced obesity. Obesity. 
2012; 20(6):1189–1199. [PubMed: 22252034] 
Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells 
contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature 
Medicine. 2009; 15(8):914–920.
Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and 
lipolysis. The Journal of Biological Chemistry. 1964; 239:375–380. [PubMed: 14169133] 
Singer K, Morris DL, Oatmen KE, Wang T, DelProposto J, Mergian T, et al. Neuropeptide Y is 
produced by adipose tissue macrophages and regulates obesity-induced inflammation. PLoS One. 
2013; 8(3):e57929. [PubMed: 23472120] 
Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment and Th1 
polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity. 2010; 18(10):
1918–1925. [PubMed: 20111012] 
Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, Jick Z, et al. Adipocyte death, 
adipose tissue remodeling, and obesity complications. Diabetes. 2007; 56(12):2910–2918. 
[PubMed: 17848624] 
Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J, et al. Neutrophils mediate insulin 
resistance in mice fed a high-fat diet through secreted elastase. Nature Medicine. 2012; 18(9):
1407–1412.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated 
with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation. 2003; 
112(12):1796–1808. [PubMed: 14679176] 
Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al. Pro-inflammatory 
CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human 
obesity. Diabetes. 2010; 59(7):1648–1656. [PubMed: 20357360] 
Westcott DJ, Delproposto JB, Geletka LM, Wang T, Singer K, Saltiel AR, et al. MGL1 promotes 
adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. The 
Journal of Experimental Medicine. 2009; 206(13):3143–3156. [PubMed: 19995956] 
Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils 
sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 
2011; 332(6026):243–247. [PubMed: 21436399] 
Cho et al. Page 12
Methods Enzymol. Author manuscript; available in PMC 2014 November 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial 
role in the development of obesity-related insulin resistance. The Journal of Clinical Investigation. 
2003; 112(12):1821–1830. [PubMed: 14679177] 
Cho et al. Page 13
Methods Enzymol. Author manuscript; available in PMC 2014 November 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 16.1. 
Gating strategy to identify and characterize ATMs. (A) Gating strategy for the identification 
of M1 (CD11c+) and M2 (CD301+) ATMs according to the flow cytometry protocol 
described herein. (B) Histograms of Gr-1 and Siglec-F expression on CD11bhighF4/80high 
(gate 1), CD11bmid/highF4/80dim (gate 2), and CD11b−F4/80− (gate 3) SVCs demonstrates 
that the CD11bmid/highF4/80dim population (gate 2) can be contaminated with neutrophils 
(Gr-1) and eosinophils (Siglec-F).
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Figure 16.2. 
Enrichment of CD11b+ SVCs using magnetic beads. SVCs were isolated as described in 
Section 3.1 and CD11b+ cells were positively selected using Miltenyi microbeads as 
described in Section 3.5. Unsorted and sorted cells were analyzed by flow cytometry. (A) 
Scatterplots showing CD45 versus CD11b expression on unsorted (left), CD11b-depleted 
(CD11b−; middle), and CD11b-enriched (CD11b+; right) SVCs. The percentage of total 
cells for the CD45+CD11b+ population is indicated. (B) Histogram showing enrichment 
efficiency of CD11b+ SVCs following positive selection.
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Figure 16.3. 
High-fat diet increases ATM content and alters the distribution of M1 and M2 ATMs in 
visceral fat. C57BL/6J mice were fed a normal diet (ND) or high-fat diet (HFD; 60 kcal 
from fat) for 12 weeks before stromal vascular cells (SVCs) were isolated from epididymal 
adipose tissue and examined by flow cytometry as described in these protocols. (A) 
Representative scatterplots of SVCs from ND (left) and HFD (right) mice stained with 
CD11b and F4/80. Cells are gated on viable CD45+ SVCs as shown in Fig. 16.1A. (B) 
Representative scatterplots showing gates for M1 (CD11c+CD301−) and M2 
(CD11c−CD301+) ATMs. (C) ATM content in epididymal adipose tissue shown as 
percentage of total SVCs, absolute number per fat pad, and normalized to visceral adipose 
tissue mass. (D) Distribution of ATM subsets in visceral fat from lean and obese mice 
shown as percentage of total ATMs, absolute number per fat pad, and normalized to adipose 
tissue mass. **P<0.01, ***<0.001 versus ND.
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Table 16.1
Basic antibody cocktail for ATM staining
Antibody Clone Supplier
Titrated concentration
(µg/106 cells)
F4/80 PE BM8 eBioscience 0.2
CD11b APC eFluor
780
M1/70 eBioscience 0.16
CD11c PE-Cy7 N418 eBioscience 0.2
CD45.2 PerCP-Cy5.5 104 eBioscience 0.2
CD301 Alexa Fluor
647
ER-MP23 AbD Serotec 0.2
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